How to sell private company shares · Saronic
How to sell Saronic shares
Saronic builds autonomous surface vessels for navies, and its valuation more than doubled in about a year — from $4 billion to $9.25 billion. Its secondary market looks unlike most on this site: nearly every recorded trade over the past year was a forward contract, not a transfer of shares. That fact shapes the whole question of how to sell, so this page starts with what you hold and then deals with it directly.
Start with what you hold
Employees and former employees of Saronic Technologies typically hold options or RSUs, exercised or not; early investors hold preferred bought in a round, directly or through an SPV. Shares you own can be sold where the company’s rules permit; unexercised options cannot move on their own; and an SPV interest moves under the vehicle’s own agreement first. Pull your grant documents, stock certificate or SPV subscription agreement before talking to anyone, including us — and read the transfer clause closely, because in this name it decides which structures are even available.
How Saronic liquidity actually works
Saronic has not published a void-transfer notice, and no employee tender has been announced. Its stock carries the standard controls — company approval for any transfer and a right of first refusal — plus the gate every defense name has: buyers are screened for foreign ownership, control or influence, because the cap table can touch clearances and contracts. The recorded market shows how hard the direct route has been. Of the nine Saronic secondaries recorded on PrivateMarketView from December 2025 to May 2026, seven were forward contracts and two were SPV interests, mostly on common stock; there was no recorded direct transfer. Consent is therefore the first diligence item, and the second is whether your documents allow the structure a buyer proposes.
The forward question
A forward contract pays you now against a promise to deliver shares later, usually at an IPO or sale of the company. It keeps the shares on your name and off the company’s ledger, which is why markets use it when direct transfers are hard. It is also where sellers get hurt. Many stock agreements restrict any contract to transfer or grant an interest in the shares, not just the transfer itself, and companies including OpenAI and Anthropic have said publicly that they treat unapproved forwards as void. A forward also leaves you holding the tax position, the counterparty risk and the delivery obligation for years. None of that makes forwards illegitimate — it makes them a document question. The comparison of all three structures is in direct transfer, SPV or forward.
What the stock is worth
The round history: $4 billion on a $600 million raise in February 2025, then $9.25 billion on the $1.75 billion Series D led by Kleiner Perkins, with Advent International, Bessemer, Andreessen Horowitz and Franklin Templeton, in spring 2026. The live numbers — the current mark, the round history, the recorded trade aggregates and the investor book — are maintained on the Saronic data page, published from PrivateMarketView, the data platform behind this site. None of those references is your price. A forward prices differently from a direct sale of the same stock — the buyer is pricing delivery risk and time as well as the company — and the only honest number for your block comes from buyers.
How a sale runs through this desk
Tell the desk what you hold — class, rough size, exercised or not — and your timing. We read the transfer terms in your documents first, including whether they reach forwards, and we only bring you buyers who can clear a defense company’s screening. The position goes to buyers without your name on it; if a consented direct sale is possible we pursue it before any forward, because it is the cleaner asset to sell. You are not named until you agree to proceed, there is no fee to ask, and the fee on a brokered block is quoted on your file in writing — how the fee works. The close runs through a FINRA-registered broker-dealer; our CRDs are on the about page.
Common questions
- Can I sell my Saronic shares?
- Often, yes — but only inside the company’s process. Saronic Technologies has not published a void-transfer warning of the kind OpenAI and Anthropic have, but its stock carries the standard private-company controls: a transfer needs company approval and typically faces a right of first refusal. As a defense contractor it adds a second gate — who the buyer is. The first step on any file is confirming what your specific holding can do under your documents.
- Why are most recorded Saronic trades forward contracts?
- Of the nine Saronic secondaries recorded on PrivateMarketView over the past year, seven were forward contracts and two were SPV interests; none was a direct transfer onto the company’s ledger. A forward is a promise to deliver shares later — usually at a liquidity event — for money paid now, and it is what a market uses when a direct transfer is hard to get approved. That makes it the structure to understand most carefully before signing.
- Is a forward contract a safe way to sell Saronic stock?
- It depends on what your documents say. Many private-company agreements restrict not only transfers but any contract to transfer, pledge or grant an interest in the shares, and several companies have said publicly that they treat unapproved forwards as void. A forward also leaves you holding the shares, the tax position and the counterparty risk until delivery. Read the transfer clause in your stock agreement — or have the desk do it — before any forward is priced.
- Does Saronic’s defense work affect who can buy my shares?
- Yes. Defense contractors routinely screen buyers for foreign ownership, control or influence, because a change in the cap table can touch the company’s facility clearances and contracts. In practice that narrows the buyer pool to investors the company is comfortable with and can add time to approval. A buyer who cannot pass that screen is not a buyer, however good the price.
- What is Saronic stock worth right now?
- The live reference points are the rounds — $4 billion in February 2025 and $9.25 billion at the $1.75 billion Series D led by Kleiner Perkins in spring 2026 — and the recorded secondary market. The current mark, the round history and the trade aggregates are on the Saronic data page, published from PrivateMarketView, the data platform behind this site. None of those is your price; an indication for your block comes from taking it to buyers.
- Should I wait for a Saronic IPO instead of selling?
- That is a real option with real costs. Nothing is filed and no date exists; commentary about a listing is speculation until a registration statement appears, and after one, employee and early-holder shares are typically locked up for about six months. The middle path many holders take: sell part now in a consented sale and keep the rest. The right split depends on your concentration, cash needs and taxes.
Premier Alternatives is not affiliated with Saronic Technologies. This page describes public information and market behavior as of November 3, 2026; it is not legal, tax or investment advice, and a sale of private shares deserves an hour with your tax adviser before it closes.
Read next
- The Saronic data page — valuation, rounds, trade aggregates, the investor book.
- How to sell Shield AI shares — the other defense-autonomy name, and the buyer-screening gate.
- Direct transfer, SPV or forward — the structures compared, and what a forward really commits you to.
- The process, step by step — the eight steps of any private-share sale.
- Every route to liquidity, compared — tender, broker, marketplace, forward, or wait.
Two minutes, no account. You are not named to any buyer until you agree to proceed.